☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Innoviva Specialty Therapeutics
Innoviva Specialty Therapeutics’ Xacduro Receives the US FDA’s Approval for Pneumonia Caused by Acinetobacter
May 23, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.